Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Carcinoma, Hepatocellular"" wg kryterium: Temat


Tytuł:
Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA-mRNA network and signature analysis.
Autorzy:
Wang F; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Kang X; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Li Y; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Lu J; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Liu X; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Yan H; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 29; Vol. 14 (1), pp. 5042. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Gene Regulatory Networks
Czasopismo naukowe
Tytuł:
MicroRNAs as Plasma Biomarkers of Hepatocellular Carcinoma in Patients with Liver Cirrhosis-A Cross-Sectional Study.
Autorzy:
Zenlander R; Department of Clinical Chemistry, Karolinska University Hospital, 141 86 Stockholm, Sweden.; Department of Laboratory Medicine, Karolinska Institutet, 141 52 Stockholm, Sweden.; Department of Medicine, Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden.
Salter H; Department of Laboratory Medicine, Karolinska Institutet, 141 52 Stockholm, Sweden.
Gilg S; Department of Medicine, Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden.
Eggertsen G; Department of Clinical Chemistry, Karolinska University Hospital, 141 86 Stockholm, Sweden.; Department of Medicine, Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden.
Stål P; Department of Medicine, Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden.; Division of Hepatology, Department of Upper GI Diseases, Karolinska University Hospital, 141 86 Stockholm, Sweden.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 19; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/complications
MicroRNAs*/genetics
Liver Neoplasms*/diagnosis
Liver Neoplasms*/genetics
Liver Neoplasms*/complications
Humans ; Cross-Sectional Studies ; Biomarkers, Tumor/genetics ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/genetics ; Biomarkers
Czasopismo naukowe
Tytuł:
CircGPC3 promotes hepatocellular carcinoma progression and metastasis by sponging miR-578 and regulating RAB7A/PSME3 expression.
Autorzy:
Ju L; Medical School of Nantong University, Nantong University, Institute of Liver Diseases, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People's Hospital,, 60 Middle Qingnian Road, Nantong, 226000, Jiangsu, China.
Luo Y; Medical School of Nantong University, Nantong University, Institute of Liver Diseases, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People's Hospital,, 60 Middle Qingnian Road, Nantong, 226000, Jiangsu, China.
Cui X; Medical School of Nantong University, Nantong University, Institute of Liver Diseases, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People's Hospital,, 60 Middle Qingnian Road, Nantong, 226000, Jiangsu, China.
Zhang H; Nantong Hospital Affiliated to Nanjing University of Chinese Medicine, 41 Jianshe Road, Nantong, 226009, Jiangsu, China.
Chen L; Medical School of Nantong University, Nantong University, Institute of Liver Diseases, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People's Hospital,, 60 Middle Qingnian Road, Nantong, 226000, Jiangsu, China. .
Yao M; Medical School of Nantong University, Nantong University, Institute of Liver Diseases, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People's Hospital,, 60 Middle Qingnian Road, Nantong, 226000, Jiangsu, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 01; Vol. 14 (1), pp. 7632. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
RNA, Long Noncoding*/metabolism
Humans ; RNA, Circular/genetics ; Cell Line, Tumor ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Cell Movement/genetics
Czasopismo naukowe
Tytuł:
Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma.
Autorzy:
Shabangu CS; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
Su WH; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan.; Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Li CY; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML; Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-Sen University, Kaohsiung, Taiwan.; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.; Hepatitis Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
Dai CY; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.; Hepatitis Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
Huang JF; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.; Hepatitis Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
Chuang WL; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.; Hepatitis Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
Wang SC; Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan. .; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan. .; Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-Sen University, Kaohsiung, Taiwan. .; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Mar 12; Vol. 22 (1), pp. 268. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
MicroRNAs*/genetics
Hepatitis C*
Humans ; Hepacivirus/genetics ; Gene Expression Profiling ; RNA, Messenger/genetics
Czasopismo naukowe
Tytuł:
Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases.
Autorzy:
Ferro A; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Saccu G; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Mattivi S; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Gaido A; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Herrera Sanchez MB; 2i3T, Società per la Gestione Dell'incubatore di Imprese e per il Trasferimento Tecnologico, University of Torino, 10126 Turin, Italy.; Molecular Biotechnology Centre 'Guido Tarone', 10126 Turin, Italy.
Haque S; Research and Scientific Studies Unit, College of Nursing and Health Sciences, Jazan University, Jazan 45142, Saudi Arabia.; Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 13306, United Arab Emirates.; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut 1102 2801, Lebanon.
Silengo L; Molecular Biotechnology Centre 'Guido Tarone', 10126 Turin, Italy.
Altruda F; Molecular Biotechnology Centre 'Guido Tarone', 10126 Turin, Italy.
Durazzo M; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Fagoonee S; Institute for Biostructure and Bioimaging, National Research Council (CNR), Molecular Biotechnology Centre 'Guido Tarone', 10126 Turin, Italy.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Feb 26; Vol. 14 (3). Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
RNA, Long Noncoding*/genetics
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
MicroRNAs*/genetics
Extracellular Vesicles*/metabolism
Fatty Liver*/pathology
Humans ; RNA, Untranslated/physiology ; Biomarkers/metabolism ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/genetics ; Liver Cirrhosis/pathology
Czasopismo naukowe
Tytuł:
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3.
Autorzy:
Yuan LX; Institute of Liver Diseases, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, 226000, Nantong, Jiangsu, China.
Luo M; Nantong Third People's Hospital, Medical School of Nantong University, 226000, Nantong, Jiangsu, China.
Liu RY; Medical School of Nantong University, Affiliated Hospital of Nantong University, 226000, Nantong, Jiangsu, China.
Wang HX; Institute of Liver Diseases, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, 226000, Nantong, Jiangsu, China.
Ju LL; Institute of Liver Diseases, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, 226000, Nantong, Jiangsu, China.
Wang F; Medical School of Nantong University, Affiliated Hospital of Nantong University, 226000, Nantong, Jiangsu, China.
Cao YL; Preventive Health Department, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, 226000, Nantong, Jiangsu, China.
Wang ZC; Hepatology Department of integrated Chinese and Western Medicine, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, 226000, Nantong, Jiangsu, China. .
Chen L; Institute of Liver Diseases, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, 226000, Nantong, Jiangsu, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 21; Vol. 24 (1), pp. 239. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
MicroRNAs*/genetics
Humans ; RNA, Circular/genetics ; RNA, Circular/metabolism ; Down-Regulation ; Cell Line, Tumor ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Eukaryotic Initiation Factor-4A/genetics ; Eukaryotic Initiation Factor-4A/metabolism ; DEAD-box RNA Helicases/genetics
Czasopismo naukowe
Tytuł:
Construction of a ceRNA regulatory network to explore potential pathogenesis mechanisms involved in human hepatocellular carcinoma.
Autorzy:
Liu Y; Department of Gastroenterology and Hepatology, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, No. 60 Middle Qingnian Road, Nantong, 226001, Jiangsu, China.
Dong Z; Nantong University Medical School, Nantong, 226001, Jiangsu, China.
Chen W; Nantong University Medical School, Nantong, 226001, Jiangsu, China.
Chen L; Department of Hepatology Laboratory, Nantong Institute of Liver Disease, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, No. 60 Middle Qingnian Road, Nantong, 226001, Jiangsu, China.
Ju L; Department of Hepatology Laboratory, Nantong Institute of Liver Disease, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, No. 60 Middle Qingnian Road, Nantong, 226001, Jiangsu, China.
Cai W; Department of Hepatobiliary Surgery, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, No. 60 Middle Qingnian Road, Nantong, 226001, Jiangsu, China.
Luo X; Department of Clinical Laboratory, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, No. 60 Middle Qingnian Road, Nantong, 226001, Jiangsu, China. .
Bian Z; Department of Gastroenterology and Hepatology, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, No. 60 Middle Qingnian Road, Nantong, 226001, Jiangsu, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 12; Vol. 13 (1), pp. 22058. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; RNA, Competitive Endogenous ; RNA, Circular/genetics ; Gene Regulatory Networks ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł:
Ultrasound-triggered release of miR-199a-3p from liposome nanobubbles for enhanced hepatocellular carcinoma treatment.
Autorzy:
Guo X; Department of Ultrasound, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Lin J; Department of Ultrasound, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Pan L; Department of Endocrinology, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
He K; Department of Ultrasound, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Huang Z; Department of Nuclear Medicine, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Chen J; Department of Ultrasound, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Lin C; Department of Ultrasound, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Zeng B; Department of Ultrasound, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Luo S; Department of Ultrasound, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Wang M; Department of Ultrasound, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Pokaż więcej
Źródło:
Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2023 Dec; Vol. 51 (1), pp. 560-571. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/therapy
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/genetics
Liver Neoplasms*/therapy
Liver Neoplasms*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; Liposomes ; Oligopeptides/metabolism ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Long Noncoding RNA Cytoskeleton Regulator RNA Suppresses Apoptosis in Hepatoma Cells by Modulating the miR-125a-5p/HS1-Associated Protein X-1 Axis to Induce Caspase-9 Inactivation.
Autorzy:
Wu ZY; Department of Hepatobiliary Surgery, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.
Wang Y; Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.
Hu H; Department of Hepatobiliary Surgery, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.
Ai XN; Department of Hepatobiliary Surgery, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.
Zhang Q; Department of Hepatobiliary Surgery, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.
Qin YG; Department of Hepatobiliary Surgery, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2023 Nov 15; Vol. 17 (6), pp. 916-925. Date of Electronic Publication: 2023 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
RNA, Long Noncoding*/genetics
Humans ; Caspase 9/genetics ; Caspase 9/metabolism ; Cell Line, Tumor ; Cytoskeleton/metabolism ; Cytoskeleton/pathology ; Apoptosis/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma.
Autorzy:
Boonkaew B; Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Satthawiwat N; Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Pinjaroen N; Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Chuaypen N; Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Tangkijvanich P; Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 07; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/diagnosis
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Non-alcoholic Fatty Liver Disease*
Extracellular Vesicles*/genetics
Extracellular Vesicles*/pathology
Humans ; Prognosis ; Biomarkers, Tumor/genetics ; Biomarkers
Czasopismo naukowe
Tytuł:
Circular RNA DNAH14 molecular mechanism in an experimental model of hepatocellular carcinoma treated with Cobalt chloride to mimic the hypoxia-like response of transcatheter arterial chemoembolization.
Autorzy:
Liao Q; Department of Radiology, The Second Xiangya Hospital of Central South University, No. 139, Renmin Middle Road, Changsha City, 410011, Hunan Province, China.
Xia W; Department of Urology Surgery, Xiangya Hospital Central South University, No. 87 Xiangya Road, Kaifu District, Changsha City, 410008, Hunan Province, China.
Chen J; Department of Urology Surgery, Xiangya Hospital Central South University, No. 87 Xiangya Road, Kaifu District, Changsha City, 410008, Hunan Province, China.
Wang K; Department of Urology Surgery, Xiangya Hospital Central South University, No. 87 Xiangya Road, Kaifu District, Changsha City, 410008, Hunan Province, China. .
Xiao E; Department of Radiology, The Second Xiangya Hospital of Central South University, No. 139, Renmin Middle Road, Changsha City, 410011, Hunan Province, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 23; Vol. 14 (1), pp. 1992. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*
Chemoembolization, Therapeutic*
Cobalt*
Liver Neoplasms*
MicroRNAs*
RNA, Circular*
Animals ; Humans ; Mice ; Dyneins ; Models, Theoretical ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study.
Autorzy:
Sartorius K; Faculty of Commerce, Law and Management, University of the Witwatersrand, Johannesburg 2001, South Africa.; School of Laboratory Medicine and Molecular Sciences, University of Kwazulu-Natal, Durban 4041, South Africa.; Africa Hepatopancreatobiliary Cancer Consortium (AHPBCC), Mayo Clinic, Jacksonville, FL 32224, USA.
Sartorius B; School of Public Health, University of Queensland, Brisbane, QLD 4102, Australia.
Winkler C; Centre for Cancer Research, Basic Research Laboratory, National Cancer Institute, Frederick Natifol Laboratory for Cancer Research, National Institute of Health, Frederick, MD 21701, USA.
Chuturgoon A; School of Laboratory Medicine and Molecular Sciences, University of Kwazulu-Natal, Durban 4041, South Africa.
Shen TW; CCR-SF Bioinformatics Group, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
Zhao Y; CCR-SF Bioinformatics Group, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
An P; Centre for Cancer Research, Basic Research Laboratory, National Cancer Institute, Frederick Natifol Laboratory for Cancer Research, National Institute of Health, Frederick, MD 21701, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 12; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
Hepatitis B*/complications
Hepatitis B*/genetics
MicroRNAs*/genetics
Humans ; South Africa/epidemiology
Czasopismo naukowe
Tytuł:
A hsa_circ_001726 axis regulated by E2F6 contributes to metastasis of hepatocellular carcinoma.
Autorzy:
Ai J; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Zhang W; Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Deng W; Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Yan L; Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Zhang L; Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Huang Z; Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Wu Z; Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Ai J; Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. .
Jiang H; Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 14. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
E2F6 Transcription Factor*
Liver Neoplasms*/genetics
RNA, Circular*/genetics
Animals ; Humans ; Mice ; Cell Line, Tumor ; Cell Proliferation/genetics ; Disease Models, Animal ; Gene Expression Regulation, Neoplastic ; In Situ Hybridization, Fluorescence ; MicroRNAs/genetics
Czasopismo naukowe
Tytuł:
Circ_MAPK9 promotes STAT3 and LDHA expression by silencing miR-642b-3p and affects the progression of hepatocellular carcinoma.
Autorzy:
Wang K; Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road, Guangzhou, Guangdong, China.
Lu Q; Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road, Guangzhou, Guangdong, China.
Luo Y; Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road, Guangzhou, Guangdong, China.
Yu G; Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road, Guangzhou, Guangdong, China.
Wang Z; Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road, Guangzhou, Guangdong, China.
Lin J; Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road, Guangzhou, Guangdong, China.
Tan Z; Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road, Guangzhou, Guangdong, China.
Lao Y; Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road, Guangzhou, Guangdong, China.
Liu S; Guangzhou Institute of Cardiovascular Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Yang H; Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road, Guangzhou, Guangdong, China. .
Pokaż więcej
Źródło:
Biology direct [Biol Direct] 2024 Jan 02; Vol. 19 (1), pp. 4. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
MicroRNAs*/genetics
Animals ; Mice ; Humans ; STAT3 Transcription Factor/genetics ; In Situ Hybridization, Fluorescence ; Mice, Nude ; Cell Proliferation ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
Hepatitis B Virus and microRNAs: A Bioinformatics Approach.
Autorzy:
Zulian V; Virology Laboratory, National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, 00149 Rome, Italy.
Fiscon G; Department of Computer, Control and Management Engineering, Sapienza University of Rome, 00185 Rome, Italy.; Institute for Systems Analysis and Computer Science 'Antonio Ruberti', National Research Council, 00185 Rome, Italy.
Paci P; Department of Computer, Control and Management Engineering, Sapienza University of Rome, 00185 Rome, Italy.; Institute for Systems Analysis and Computer Science 'Antonio Ruberti', National Research Council, 00185 Rome, Italy.
Garbuglia AR; Virology Laboratory, National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, 00149 Rome, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 07; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
MicroRNAs*/genetics
MicroRNAs*/metabolism
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/metabolism
Hepatitis B*/genetics
Hepatitis B, Chronic*
Humans ; Hepatitis B virus ; Computational Biology
Czasopismo naukowe
Tytuł:
Significant CircRNAs in liver cancer stem cell exosomes: mediator of malignant propagation in liver cancer?
Autorzy:
Han T; Department of Medical Oncology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China.
Chen L; Department of Medical Oncology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China.; Postgraduate College, China Medical University, 77 Puhe Road, North New District, Shenyang, Liaoning Province, 110122, China.; Department of Medical Oncology, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenhe District, Shenyang, Liaoning Province, 110017, China.
Li K; Department of Medical Oncology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China.
Hu Q; Department of Medical Oncology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China.
Zhang Y; Department of Oncology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, No. 358 Datong Road, Pudong New Area, Shanghai, 200137, China.
You X; Postgraduate College, China Medical University, 77 Puhe Road, North New District, Shenyang, Liaoning Province, 110122, China.
Han L; Department of Hepatobiliary Surgery, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenhe District, Shenyang, Liaoning Province, 110017, China.
Chen T; Department of Oncology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, No. 358 Datong Road, Pudong New Area, Shanghai, 200137, China. .
Li K; Department of Gastrointestinal Oncology Surgery, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2023 Dec 05; Vol. 22 (1), pp. 197. Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Neoplasms*/pathology
Carcinoma, Hepatocellular*/pathology
Exosomes*/genetics
Exosomes*/pathology
MicroRNAs*
Humans ; RNA, Circular/genetics ; Cell Line, Tumor ; Neoplastic Stem Cells/pathology
Raport
Tytuł:
Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker.
Autorzy:
Wu Q; College of Life Science, Yangtze University, Jingzhou 434025, China.
Wang P; College of Life Science, Yangtze University, Jingzhou 434025, China.
Peng Q; College of Life Science, Yangtze University, Jingzhou 434025, China.
Kang Z; College of Life Science, Yangtze University, Jingzhou 434025, China.
Deng Y; College of Life Science, Yangtze University, Jingzhou 434025, China.
Li J; College of Life Science, Yangtze University, Jingzhou 434025, China.
Chen Y; College of Life Science, Yangtze University, Jingzhou 434025, China.
Li J; College of Life Science, Yangtze University, Jingzhou 434025, China.
Ge F; State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan 430072, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 30; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; Cell Proliferation/genetics ; Neutrophils/metabolism ; Prognosis ; Receptors, G-Protein-Coupled/genetics
Czasopismo naukowe
Tytuł:
EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
Autorzy:
Wang K; Department of digestive surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.; Department of General Surgery, Central Theater Command General Hospital of the Chinese People's Liberation Army, Wuhan, 430064, China.; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, 710032, China.
Jiang X; Department of digestive surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, 710032, China.
Jiang Y; Department of Hepatobiliary Surgery, XI'AN DAXING hospital, Xi'an, 710032, China.
Liu J; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, 710032, China.
Du Y; Department of digestive surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, 710032, China.
Zhang Z; Department of digestive surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, 710032, China.
Li Y; Department of digestive surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Zhao X; Department of Thyroid and Breast Surgery, Xi'an No.3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, 710018, China.
Li J; Department of digestive surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China. .; Department of Experimental Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China. .
Zhang R; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, 710032, China. .; State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xi'an, 710032, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Nov 27; Vol. 42 (1), pp. 320. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Animals ; Humans ; Mice ; Carcinogenesis/genetics ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cellular Senescence/genetics ; DNA Topoisomerases, Type II/genetics ; DNA Topoisomerases, Type II/metabolism ; Enhancer of Zeste Homolog 2 Protein/genetics ; Enhancer of Zeste Homolog 2 Protein/metabolism ; Epigenesis, Genetic ; Gene Expression Regulation, Neoplastic ; Histones/metabolism ; Mice, Nude
Czasopismo naukowe
Tytuł:
Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers.
Autorzy:
Ranković B; Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia.
Hauptman N; Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 22; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Circulating MicroRNA*/genetics
MicroRNAs*/genetics
Liver Neoplasms*/diagnosis
Liver Neoplasms*/genetics
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/genetics
Humans ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
Distinct Morphological and Molecular Profiles of NAFLD and NAFLD-associated HCC Revealed by Immunohistochemistry and MicroRNA Analysis.
Autorzy:
Rusu I; Iuliu Hatieganu University of Medicine and Pharmacy, Department of Pathology, Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania. . .
Pirlog R; Iuliu Hatieganu University of Medicine and Pharmacy, Research Center for Functional Genomics, Biomedicine and Translational Medicine, Cluj-Napoca, Romania; Department of Pathology, Institute Curie, Saint-Cloud, France. .
Chiroi P; Iuliu Hatieganu University of Medicine and Pharmacy, Research Center for Functional Genomics, Biomedicine and Translational Medicine, Cluj-Napoca, Romania. .
Nutu A; Iuliu Hatieganu University of Medicine and Pharmacy, Research Center for Functional Genomics, Biomedicine and Translational Medicine, Cluj-Napoca, Romania. .
Budisan L; Iuliu Hatieganu University of Medicine and Pharmacy, Research Center for Functional Genomics, Biomedicine and Translational Medicine, Cluj-Napoca, Romania. .
Puia VR; Iuliu Hatieganu University of Medicine and Pharmacy, 3rd Department of General Surgery, Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania. .
Braicu C; Iuliu Hatieganu University of Medicine and Pharmacy, Research Center for Functional Genomics, Biomedicine and Translational Medicine, Cluj-Napoca, Romania. .
Berindan-Neagoe I; Iuliu Hatieganu University of Medicine and Pharmacy, Research Center for Functional Genomics, Biomedicine and Translational Medicine, Cluj-Napoca, Romania. .
Al Hajjar N; 3rd Department of General Surgery, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania; Iuliu Hatieganu University of Medicine and Pharmacy, Research Center for Functional Genomics, Biomedicine and Translational Medicine, Cluj-Napoca, Romania. na_.
Pokaż więcej
Źródło:
Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2023 Sep 28; Vol. 32 (3), pp. 356-366. Date of Electronic Publication: 2023 Sep 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/epidemiology
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/genetics
Non-alcoholic Fatty Liver Disease*/complications
MicroRNAs*/genetics
Liver Neoplasms*/diagnosis
Liver Neoplasms*/genetics
Liver Neoplasms*/epidemiology
Diabetes Mellitus, Type 2*/complications
Humans ; Male ; Female ; beta Catenin/genetics ; Immunohistochemistry
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies